# A Study of Genetic and Environmental Factors and Their Effect on Response to Treatment With Lucentis (Ranibizumab) for Wet AMD

> **NCT00469352** · PHASE3 · COMPLETED · sponsor: **Oregon Health and Science University** · enrollment: 150 (estimated)

## Conditions studied

- Macular Degeneration

## Interventions

- **DRUG:** Ranibizumab

## Key facts

- **NCT ID:** NCT00469352
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2011-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00469352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00469352, "A Study of Genetic and Environmental Factors and Their Effect on Response to Treatment With Lucentis (Ranibizumab) for Wet AMD". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00469352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*